摘要 |
The invention relates to the use of a preparation based on -an antibody directed against a tumor-associated glycosylation for preparing a medicament for the prophylactic and/or therapeutic treatment for the reduction or inhibition, respectively, of the growth of tumor cells in a cancer patient, as well as to a pharmaceutical preparation containing an antibody directed against a tumor-associated glycosylation. Moreover, the invention relates to a preparation for pharmaceutical and/or diagnostic use, a diagnostic method and an agent for determining the risk of metastasis formation in a cancer patient, as well as a method of producing a preparation based on a body fluid or tissue, in each case using the antibody directed against a tumor-associated glycosylation. |
申请人 |
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG;LOIBNER, HANS;HIMMLER, GOTTFRIED;PUTZ, THOMAS;FREISSMUTH, MICHAEL;KLINGER, MARKUS;FARHAN, HESSO |
发明人 |
LOIBNER, HANS;HIMMLER, GOTTFRIED;PUTZ, THOMAS;FREISSMUTH, MICHAEL;KLINGER, MARKUS;FARHAN, HESSO |